Lansen Pharmaceutical Holdings Limited (00503)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chan Eliza Ching Har | 10-Feb-22 | 19-Dec-23 | INED | ||
| Chan Michael Kee Huen | 09-Apr-10 | 19-Dec-23 | INED | ||
| Chan Sheung Chi | 31-Aug-09 | 25-Sep-10 | CoSec, CFO | ||
| Chen Li | 01-Mar-18 | CEO | |||
| Horlacher Fritz Heinrich | 10-Feb-11 | 10-Feb-22 | INED | Due to his desire to devote more time to his other personal commitments over 10 years of service in the Company | |
| Hou Song | 30-Mar-16 | 20-Oct-18 | FD | ||
| 16-Sep-15 | 30-Mar-16 | CFO | |||
| Hunt Stephen Burnau | 30-Mar-17 | 09-Apr-22 | NED | Retired after serving on the Board for 12 years | |
| 09-Apr-10 | 30-Mar-17 | Ch | |||
| Lee Jin Yi | 09-Apr-10 | 31-Oct-19 | Dep Ch, NED | ||
| Leung Tsz Chun | 16-Sep-15 | 22-Jun-18 | CoSec | ||
| Liu Bang Min | 09-Apr-13 | 31-Jan-18 | CEO | ||
| Liu Xiaodong | 08-Jan-10 | 14-Dec-12 | ED | ||
| Liu Xuezi | 30-Mar-16 | NED | |||
| Mui Clarence Chi Hung | 18-Feb-11 | 16-Sep-15 | CoSec, CFO | ||
| Pang Kai Fai | 13-Jun-19 | CoSec | |||
| Tang Jun | 09-Apr-10 | 30-Mar-17 | NED | ||
| Tang Raymond Chiu Ping | 09-Apr-10 | 09-Apr-19 | INED | ||
| Tao Fang Fang | 08-Jan-10 | 30-Mar-16 | NED | ||
| Thian Robert Peter | 09-Apr-10 | 10-Feb-11 | Dep Ch, INED | ||
| Wu Zhentao | 30-Mar-17 | Ch, NED | |||
| Xu Jun | 08-Jan-10 | 08-Apr-13 | CEO | ||
| Yeung Allen Tak Bun | 06-Oct-18 | 19-Dec-23 | INED | ||
| Yip Rebecca Pui Ling | 25-Sep-10 | 18-Feb-11 | CoSec | ||
| 10-Sep-09 | 25-Sep-10 | NED | |||
| Yiu Chi Hung | 22-Jun-18 | 13-Jun-19 | CoSec | ||
| Zhu Xun | 23-Sep-22 | 19-Dec-23 | INED |